JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

B5926 AZD-5597

Summary: Potent CDK inhibitor

≥1.82 mg/mL
A8882 THZ1
12 Citation

Target: Cyclin-Dependent Kinases

Summary: Covalent CDK7 inhibitor,potent and selective

≥28.3 mg/mL
B3707 ML167

Target: Clk

Summary: Clk4 inhibitor,highly selective

insoluble in EtOH; insoluble in H2O; ≥16.75 mg/mL
B4736 THZ1 Hydrochloride

Target: Cyclin-Dependent Kinases

Summary: CDK7 inhibitor

≥30.13 mg/mL
B6720 Kenpaullone

Summary: CDK1/cyclin B and GSK-3β inhibitor

insoluble in H2O; insoluble in EtOH; ≥17.65 mg/mL
B7063 Arcyriaflavin A

Summary: cdk4/cyclin D1 inhibitor

Soluble in DMSO
B5220 [Ala92]-p16 (84-103)

Summary: inhibitor of cyclin-dependent kinase-4 (cdk4)/cyclin D1

Soluble to 2 mg/mL
B6935 Aminopurvalanol A

Target: Cyclin-Dependent Kinases

Summary: cyclin-dependent kinase inhibitor

Soluble in DMSO
B6956 NSC 625987

Summary: Cyclin-dependent kinase (cdk) 4 inhibitor

insoluble in ethanol; <27.13 mg/mL
B7128 Ryuvidine

Summary: SETD8 protein lysine methyltransferase (PKMT) inhibitor

Soluble in DMSO